Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
amobarbital + Gel-One
- Development stage
- Preclinical
- Modality
- Hydrogel Systems → Drug Delivery Systems, Small Molecules
- Administration
- Intraarticular
01
Overview
A novel formulation combining amobarbital, a barbiturate derivative that functions as a mitochondrial electron transport chain complex I inhibitor, with Gel-One, a crosslinked hyaluronic acid (HA) hydrogel. This combination is designed as a drug delivery system for the treatment of post-traumatic osteoarthritis (PTOA). Amobarbital reduces oxidative damage and chondrocyte death by inhibiting mitochondrial complex I, while the HA hydrogel serves as a depot-style drug delivery vehicle that remains at the intra-articular injection site for extended periods, improving the long-term efficacy of amobarbital.
- Other names
- amobarbital/HA hydrogel
02
Targets
GABRR (GABA-A receptor subunit rho)ND1 (Mitochondrial electron transport chain complex I)AMPAR (AMPA receptor)Nicotinic Acetylcholine Receptor
Beyond the preview
Go deeper on amobarbital + Gel-One.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on amobarbital + Gel-One.